IL10 and hepatocellular carcinoma: Figure 5 shows that Resminostat (80 nM) reduced the mRNA levels of VEGF, leptin, STAT3, TNFα and increased expression levels of IL-10 in HCC cells treated with adipocyte CM after 24 hours (Figure 5A).